Estimates of Current Capacity for Diagnosing Alzheimer’s Disease in Sweden and the Need to Expand Specialist Numbers
This is my archive
Implications of treatment duration and frequency for value and cost-effective price of Alzheimer treatmentsImplications of treatment duration and frequency for value and cost-effective price of Alzheimer treatments
Medical Costs and Caregiver Burden of Delivering Disease-Modifying Alzheimer’s Treatments with Different Duration and Route of Administration.
Economic Impact of Progression from Mild Cognitive Impairment to Alzheimer Disease in the United States
Estimated Investment Need to Increase England’s Capacity to Diagnose Eligibility for an Alzheimer’s Treatment to G7 Average Capacity Levels
A chance to prevent Alzheimer’s disease sooner than you think
Health Economic Considerations in the Deployment of an Alzheimer’s Prevention Therapy
Estimates of Current Capacity for Diagnosing Alzheimer’s Disease in Sweden and the Need to Expand Specialist Numbers
Projecting the long-term societal value of a disease-modifying treatment for Alzheimer’s disease in the United States
Developing a pathway to support the appropriate, affordable, and widespread use of effective Alzheimer’s prevention drugs
